Metraipolis › archive › dc_41db5e82b6de
TIGIT in cancer: from mechanism of action to promising immunotherapeutic strategies — Europe PMC PMID:40890162
- Source
- Europe PMC (en)
- Original
- https://europepmc.org/article/MED/40890162
- DOI
- 10.1038/s41419-[numero omesso]-4
- License (as archived)
- solo-consultazione
- Archived
- 2026-11-10T05:29:24.507Z
- SHA-256 of the archived text
d22e2824c5828fb1a7d37340c89280a49890979c1842115a7347a4886621feeb- Stable URL of this page
https://metraipolis.com/documento/dc_41db5e82b6de
How to cite
TIGIT in cancer: from mechanism of action to promising immunotherapeutic strategies — Europe PMC PMID:40890162 — Europe PMC (en), https://europepmc.org/article/MED/40890162 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_41db5e82b6de (Metraipolis archive dc_41db5e82b6de, sha256 d22e2824c5828fb1a7d37340c89280a49890979c1842115a7347a4886621feeb)
BibTeX
@misc{dc41db5e82b6de,
title = {TIGIT in cancer: from mechanism of action to promising immunotherapeutic strategies — Europe PMC PMID:40890162},
howpublished = {Europe PMC (en)},
url = {https://europepmc.org/article/MED/40890162},
note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_41db5e82b6de; sha256 d22e2824c5828fb1a7d37340c89280a49890979c1842115a7347a4886621feeb},
year = {2026}
}Archived text
The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/40890162. Agents can read the archived copy with the MCP tool read_document.